Budesonide D8
| Product Name | Budesonide D8 |
|---|---|
| Alternate Names | Budesonide Stable Isotopes, Stable Isotopes of Budesonide |
| CAT No. | CS-O-06449 |
| CAS No. | 1105542-94-6 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 438.58 g/mol |
| Mol. For. | C₂₅H₂₆D₈O₆ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Budesonide |
| Purity | 95% |
| Therapeutic | Anti-Asthma / COPD |
| Smileys | O=C([C@]([C@@]1([H])C[C@@]2([H])[C@@](CCC3=CC4=O)([H])[C@]([C@]3(C=C4)C)([H])[C@@H](O)C5)(OC(C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])([2H])O1)[C@]25C)CO |
| Canonical Smiles | CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C |
| InchIKey | VOVIALXJUBGFJZ-SMANYZGRSA-N |
| Inchl | InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1/i1D3,4D2,5D2,21D |
| IUPAC | (1S,2S,4R,8S,9S,11S,12S,13R)-6-deuterio-6-(1,1,2,2,3,3,3-heptadeuteriopropyl)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Budesonide D8 is a deuterated form of the glucocorticoid drug budesonide. It is used primarily as an inhaler medication for the treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). The deuterated form helps to improve the bioavailability and pharmacokinetics of the drug, leading to better efficacy and reduced side effects.
Budesonide D8 works by reducing inflammation in the airways, which can help to alleviate symptoms such as wheezing, shortness of breath, and coughing. It has been shown to be effective in both adults and children with asthma, and is often used as a maintenance medication to prevent exacerbations and improve lung function over time.
The chemical structure of budesonide D8 is similar to that of other glucocorticoids, with a steroid nucleus and various functional groups that confer its anti-inflammatory properties. However, the incorporation of deuterium atoms at specific positions within the molecule changes its physical and chemical properties, making it more stable and resistant to metabolism.
Overall, budesonide D8 is a valuable medication for the treatment of respiratory disorders, offering improved efficacy and safety compared to other glucocorticoids. Its precise mechanism of action and unique chemical properties make it a promising candidate for further research and development in the field of respiratory medicine.
Get an Instant Quote
Related Compounds
Budesonide D6 | Budesonide Impurity 1-D8 |